Fortrea named as leader in Pharmacovigilance Operations PEAK Matrix Assessment 2025
Fortrea has been recognized as a “Leader” for pharmacovigilance operations by Everest Group in its annual Pharmacovigilance (PV) Operations PEAK Matrix® Assessment 2025. Fortrea’s top position was recognized in both pre-and post-approval pharmacovigilance operations in Everest Group’s proprietary framework, which assesses market impact along with vision and capability.
Redefining delivery through innovation
We deliver comprehensive Phase I through IV study management, clinical pharmacology, and market access solutions to biopharma and MedTech companies around the world. We design our solutions around your needs, optimizing the development of your product and helping you advance healthcare innovation.
Breakthrough innovation starts here
We are driving a service delivery evolution with solutions that enable faster decision-making and exceptional customer experiences. Leading with science and strengthened by data, we’re shattering existing models, streamlining studies and helping sponsors bring treatments to patients faster.
With more than three decades of experience and insights, and a laser focus on customer needs, we have the breadth and depth to meet global needs, and the nimbleness to innovate at the speed of change.
Video
